Nipro Corp
TSE:8086
Intrinsic Value
Nipro Corp. engages in the manufacture and sale of medical equipment, pharmaceutical products, and glass products. [ Read More ]
The intrinsic value of one
Nipro Corp
stock under the Base Case scenario is
1 876 352.06
JPY.
Compared to the current market price of 1 257 JPY,
Nipro Corp
is
Undervalued by 100%.
Nipro Corp could be a value trap.A value trap occurs when a stock looks inexpensive based on fundamental analysis but fails to reach its intrinsic valuation over time, often due to underlying issues not reflected in quantitative data.
Scrutinize beyond numbers; assess long-term potential.
Nipro Corp's market capitalization is 205B JPY.
Nipro Corp stock price is 1 257 JPY.
Nipro Corp stock price (1257 JPY) is 100% less than its Intrinsic Value (1 876 352.06 JPY).
Nipro Corp stock price (1257 JPY) is 100% less than its DCF Value (3 748 701.9 JPY). Open DCF Valuation
Nipro Corp stock price (1257 JPY) is 69% less than its Relative Value (4 002.21 JPY). Open Relative Valuation
Nipro Corp has upside potential of 3% compared to the average analyst price target.
Open Wall St Estimates
Nipro Corp's ROIC (Return on Invested Capital) has decreased in the last 3 years from 3% to 1%.
Nipro Corp's Revenue has grown by 9% over the past 12 months.
Nipro Corp's Revenue is forecast to grow at a rate of 7% per year over the next 3 years.
Nipro Corp's ROE (Return on Equity) has decreased in the last 3 years from 9% to 4%.
Nipro Corp's ROE (Return on Equity) for the past 12 months is very low and is equal to 4%.
Nipro Corp's long-term assets (1T JPY) exceed its long-term liabilties (869B JPY).
Nipro Corp's Revenue has been growing by 9% per year for the last 3 years.
Nipro Corp has positive Operating Income for the last twelve months.
Nipro Corp's ROIC (Return on Invested Capital) for the past 12 months is very low and is equal to 1%.
Nipro Corp's short-term assets (536B JPY) exceed its short-term liabilties (358B JPY).
Nipro Corp has positive three-year average ROE (Return on Equity): 5%. The company is efficient at transforming stockholders' equity into net income.
Nipro Corp has positive Net Income for the last twelve months.
Nipro Corp has positive Gross Profit for the last twelve months.
Nipro Corp has a very low three-year average ROIC (Return on Invested Capital): 2%. The company is not efficient at using invested capital to generate operating income.
Nipro Corp's D/E (Debt to Equity) is equal to 1.84.
Nipro Corp has negative Free Cash Flow for the last twelve months.
Nipro Corp has positive Net Debt. This means that the company has more debt (448B JPY) than cash and short-term investments (79B JPY).
Nipro Corp's Altman Z-Score is very low and is equal to 0.97.
Nipro Corp generates enough operating income (27B JPY) to cover interest payments on its debt (5B JPY).
Fundamental Analysis
Nipro Corp
Balance Sheet Decomposition
Nipro Corp
| Current Assets | 536B |
| Cash & Short-Term Investments | 79.4B |
| Receivables | 177.7B |
| Other Current Assets | 278.9B |
| Non-Current Assets | 575.9B |
| Long-Term Investments | 30.8B |
| PP&E | 475.1B |
| Intangibles | 36.2B |
| Other Non-Current Assets | 33.9B |
| Current Liabilities | 358.5B |
| Accounts Payable | 81.8B |
| Accrued Liabilities | 8B |
| Short-Term Debt | 10B |
| Other Current Liabilities | 258.6B |
| Non-Current Liabilities | 510B |
| Long-Term Debt | 438.5B |
| Other Non-Current Liabilities | 71.6B |
Earnings Waterfall
Nipro Corp
|
Revenue
|
578B
JPY
|
|
Cost of Revenue
|
-404.5B
JPY
|
|
Gross Profit
|
173.6B
JPY
|
|
Operating Expenses
|
-146.7B
JPY
|
|
Operating Income
|
26.9B
JPY
|
|
Other Expenses
|
-16.7B
JPY
|
|
Net Income
|
10.2B
JPY
|
Free Cash Flow Analysis
Nipro Corp
What is Free Cash Flow?
Profitability Score
Profitability Due Diligence
Nipro Corp's profitability score is 44/100. The higher the profitability score, the more profitable the company is.
Score
Nipro Corp's profitability score is 44/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Nipro Corp's solvency score is 33/100. The higher the solvency score, the more solvent the company is.
Score
Nipro Corp's solvency score is 33/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Nipro Corp
According to Wall Street analysts, the average 1-year price target for
Nipro Corp
is 1 300.5 JPY
with a low forecast of 1 060.5 JPY and a high forecast of 1 522.5 JPY.
Shareholder Return
Price
Nipro Corp
| Average Annual Return | -5.19% |
| Standard Deviation of Annual Returns | 0.87% |
| Max Drawdown | -31% |
| Market Capitalization | 205B JPY |
| Shares Outstanding | 163 095 737 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Nipro Corp
Country
Industry
Market Cap
Dividend Yield
Description
Nipro Corp. engages in the manufacture and sale of medical equipment, pharmaceutical products, and glass products. The company is headquartered in Osaka, Osaka-Fu and currently employs 35,251 full-time employees. The firm has three segments. The Medical-Related segment involves in the sale of injections and infusions, artificial organs, high function and dialysis related medical equipment, and diabetes, generics and kits related medicine products in Japan, as well as the sales of medical devices for injection and infusion, artificial organs and diabetes in overseas markets. The Pharmaceutical-Related segment involves in the manufacture and sale of pharmaceuticals. The Pharma Packaging segment sells glass for vials and ampoules as medical glass in Japan, thermos glass for lighting and glass for lighting equipment.
You don't have any saved screeners yet
